UK Biotechs Present Novel Technologies at BioTrinity 2017
Biotechnology Rolls on Despite Brexit Uncertainty
Avoiding Costly Errors in Bioassay Development
Developers Have a Range of Options When Optimizing Bioassays for Biologics
Screening Innovations and 3D Cell Culture Assay Developments
Showcased at ELRIG
New Tech Aids Drug Discovery
In Scientific Publishing, Sharing Is Caring
The Saga for Open-Access Research Continues
Antonio Waldo Zuardi Ph.D.
Antonio Waldo Zuardi, Ph.D. ([email protected]), Department of Neurosciences and Behavior, Ribeirão Preto Medical School, University of São Paulo and INCT Translational Medicine (CNPq).
More GEN Content From This Contributor
- GEN Exclusives: Cannabidiol Does Not Convert to THC <i>In Vivo</i>